National Health Act 1953 Amendment determination under section 84AF responsible persons (No. PB 52 of 2008) (Cth)

Case
No judgment structure available for this case.

COMMONWEALTH OF AUSTRALIA

Instrument number PB 52 of 2008

Amendment determination under section 84AF of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AF of the National Health Act 1953.

Dated    1st May     2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination – responsible persons

1              Commencement

This instrument commences on 1 June 2008.

2              Amendment of PB 90 of 2007

Schedule 1 amends PB 90 of 2007.

Schedule 1        Amendments

[1]            Schedule 1, in all instances where Genepharm Australasia Limited appears in the column headed “Responsible Person”

omit from the columns in the order indicated:

Genepharm Australasia Limited 52 107 340 367

and substitute:

Genepharm Pty Ltd

68 118 734 795

[2]            Schedule 1, in all instances where Genepharm (Australia) Limited appears in the column headed “Responsible Person”

omit from the columns in the order indicated:

Genepharm (Australia) Limited 17 003 854 626

and substitute:

Genepharm Pty Ltd

68 118 734 795

[3]            Schedule 1, item dealing with Acitretin in the form Capsule 10 mg

omit from the columns in the order indicated:

Roche Products Pty Ltd 70 000 132 865

and substitute:

Actavis Australia Pty Ltd

43 122 896 468

[4]            Schedule 1, item dealing with Acitretin in the form Capsule 25 mg

omit from the columns in the order indicated:

Roche Products Pty Ltd 70 000 132 865

and substitute:

Actavis Australia Pty Ltd

43 122 896 468

[5]            Schedule 1, item dealing with Calcium in the form Tablet 250 mg (as citrate)

omit from the columns in the order indicated:

Key Pharmaceuticals Pty Ltd 21 001 215 130

and substitute:

Bayer Australia Ltd

22 000 138 714

[6]            Schedule 1, items dealing with Captopril in the form Tablet 12.5 mg

omit from the column headed “Brand”:

Genepharm Limited

and substitute:

Genepharm Pty Ltd

[7]            Schedule 1, items dealing with Captopril in the form Tablet 25 mg

omit from the column headed “Brand”:

Genepharm Limited

and substitute:

Genepharm Pty Ltd

[8]            Schedule 1, items dealing with Captopril in the form Tablet 50 mg

omit from the column headed “Brand”:

Genepharm Limited

and substitute:

Genepharm Pty Ltd

[9]            Schedule 1, items dealing with Ciprofloxacin in the form Tablet
500 mg (as hydrochloride)

omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

[10]          Schedule 1, items dealing with Ciprofloxacin in the form Tablet
750 mg (as hydrochloride)

omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

[11]          Schedule 1, after item dealing with Citalopram in the form Tablet
20 mg (as hydrobromide) (Celapram)

insert in the  columns in the order indicated:

Citalopram Tablet 20 mg (as hydrobromide) Oral Celica Ranbaxy Australia Pty Limited 17 110 871 826

[12]          Schedule 1, items dealing with Citalopram in the form Tablet
20 mg (as hydrobromide)

omit from the columns in the order indicated:

Citalopram Tablet 20 mg (as hydrobromide) Oral Citalopram-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[13]          Schedule 1, items dealing with Codeine with Paracetamol

omit from the columns in the order indicated:

Codeine with Paracetamol Tablet containing codeine phosphate
30 mg with paracetamol 500 mg
Oral Dymadon Forte GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[14]          Schedule 1, after item dealing with Drotrecogin Alfa (Activated)

insert in the columns in the order indicated:

Duloxetine

Capsule 30 mg (as hydrochloride)

Oral

Cymbalta

Eli Lilly Australia Pty Ltd

39 000 233 992

Duloxetine

Capsule 60 mg (as hydrochloride)

Oral

Cymbalta

Eli Lilly Australia Pty Ltd

39 000 233 992

[15]          Schedule 1, items dealing with Felodipine in the form Tablet
10 mg (extended release)

omit from the column headed “Brand”:

Felodipine XR 10

and substitute:

Felodil XR 10

[16]          Schedule 1, items dealing with Felodipine in the form Tablet
5 mg (extended release)

omit from the column headed “Brand”:

Felodipine XR 5

and substitute:

Felodil XR 5

[17]          Schedule 1, items dealing with Flucloxacillin

omit from the columns in the order indicated:

Flucloxacillin

Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL

Oral

Floxapen

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

[18]          Schedule 1, items dealing with Folinic acid in the form Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL

omit from the columns in the order indicated:

Leucovorin Calcium Pfizer Australia Pty Ltd 50 008 422 348

and substitute:

Leucovorin Calcium (Pfizer Australia Pty Ltd) Pfizer Australia Pty Ltd 50 008 422 348

[19]          Schedule 1, item dealing with Folinic acid in the form Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL

omit from the columns in the order indicated:

Leucovorin Calcium Hospira Australia Pty Ltd 58 097 064 330

and substitute:

Leucovorin Calcium (Hospira Australia Pty Ltd) Hospira Australia Pty Ltd 58 097 064 330

[20]          Schedule 1, items dealing with Folinic acid in the form Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL

omit from the columns in the order indicated:

Leucovorin Calcium Hospira Australia Pty Ltd 58 097 064 330
Leucovorin Calcium Pfizer Australia Pty Ltd

50 008 422 348

and substitute:

Leucovorin Calcium (Hospira Australia Pty Ltd) Hospira Australia Pty Ltd 58 097 064 330
Leucovorin Calcium (Pfizer Australia Pty Ltd) Pfizer Australia Pty Ltd 50 008 422 348

[21]          Schedule 1, item dealing with Folinic acid in the form Tablet containing calcium folinate equivalent to 15 mg folinic acid

omit from the columns in the order indicated:

Leucovorin Calcium Hospira Australia Pty Ltd 58 097 064 330

and substitute:

Leucovorin Calcium (Hospira Australia Pty Ltd) Hospira Australia Pty Ltd 58 097 064 330

[22]   Schedule 1, items dealing with Gabapentin in the form Tablet
600 mg

omit from the columns in the order indicated:

Gabapentin Tablet 600 mg Oral Pharmacor Gabapentin 600 Pharmacor Pty Limited 58 121 020 835

[23]          Schedule 1, items dealing with Gabapentin in the form Tablet
800 mg

omit from the columns in the order indicated:

Gabapentin Tablet 800 mg Oral Pharmacor Gabapentin 800 Pharmacor Pty Limited 58 121 020 835

[24]          Schedule 1, after items dealing with Glucose and Ketone Indicator ─ Urine

insert in the columns in the order indicated:

Glucose Indicator─ Blood Electrode strips, 100 (FreeStyle Lite) For external use FreeStyle Lite Abbott Australasia Pty Ltd 95 000 180 389

[25]          Schedule 1, items dealing with Glucose Indicator—Blood in the form Electrode strips, 50 with the brands Glucocard 01 Sensor, GlucoCare Super Sensor and GlucoOz

omit from the column headed “Responsible Person:

Medical Specialities Australia Unit Trust

and substitute:

Medical Specialties Australia Unit Trust

[26]          Schedule 1, items dealing with Hydrochlorothiazide with Amiloride

omit from the columns in the order indicated:

Hydrochlorothiazide with Amiloride

Tablet containing  hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg

Oral

Amizide

Alphapharm Pty Limited

93 002 359 739

[27]          Schedule 1, after item dealing with Meloxicam in the form Tablet
15 mg (Meloxicam Sandoz)

insert in the columns in the order indicated:

Meloxicam Tablet 15 mg Oral Meloxicam Winthrop sanofi-aventis Australia Pty Ltd 31 008 558 807

[28]          Schedule 1, after item dealing with Meloxicam in the form Tablet
7.5 mg (Meloxicam Sandoz)

insert in the columns in the order indicated:

Meloxicam Tablet 7.5 mg Oral Meloxicam Winthrop sanofi-aventis Australia Pty Ltd 31 008 558 807

[29]          Schedule 1, items dealing with Metformin in the form Tablet
containing metformin hydrochloride 500 mg

omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

[30]          Schedule 1, items dealing with Metformin in the form Tablet
containing metformin hydrochloride 850 mg

omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

[31]          Schedule 1, items dealing with Norfloxacin

omit from the column headed “Brand”:

Genepharm Limited

and substitute:

Genepharm Pty Ltd

[32]          Schedule 1, items dealing with Oxaliplatin

(a)omit from the columns in the order indicated:

Oxaliplatin Powder for I.V. infusion 100 mg Injection Oxaliplan 100 Willow Pharmaceuticals Pty Ltd 80 118 534 704

(b)omit from the columns in the order indicated:

Oxaliplatin Powder for I.V. infusion 50 mg Injection Oxaliplan 50 Willow Pharmaceuticals Pty Ltd 80 118 534 704

[33]          Schedule 1, after items dealing with Potassium Chloride with Potassium Bicarbonate

insert in the columns in the order indicated:

Pramipexole Tablet containing pramipexole hydrochloride 1 mg Oral Sifrol Boehringer Ingelheim Pty Ltd 52 000 452 308
Pramipexole Tablet containing pramipexole hydrochloride 125 micrograms Oral Sifrol Boehringer Ingelheim Pty Ltd 52 000 452 308
Pramipexole Tablet containing pramipexole hydrochloride 250 micrograms Oral Sifrol Boehringer Ingelheim Pty Ltd 52 000 452 308

[34]          Schedule 1, items dealing with Pravastatin in the form Tablet
containing pravastatin sodium 10 mg

omit from the columns in the order indicated:

Pravastatin Tablet containing pravastatin sodium
10 mg
Oral Pravastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[35]          Schedule 1, items dealing with Pravastatin in the form Tablet
containing pravastatin sodium 20 mg

omit from the columns in the order indicated:

Pravastatin Tablet containing pravastatin sodium
20 mg
Oral Pravastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[36]          Schedule 1, items dealing with Pravastatin in the form Tablet
containing pravastatin sodium 40 mg

omit from the columns in the order indicated:

Pravastatin Tablet containing pravastatin sodium
40 mg
Oral Pravastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[37]          Schedule 1, after item dealing with Quinapril in the form Tablet
20 mg (as hydrochloride) (Pharmacor Quinapril 20)

insert in the columns in the order indicated:

Quinapril Tablet 20 mg (as hydrochloride) Oral Quinapril Sandoz Sandoz Pty Ltd 60 075 449 553

[38]          Schedule 1, item dealing with Raltitrexed

omit from the columns in the order indicated:

AstraZeneca Pty Ltd 54 009 682 311

and substitute:

Hospira Pty Ltd

13 107 058 328

[39]          Schedule 1, items dealing with Roxithromycin in the form Tablet
150 mg

omit from the columns in the order indicated:

Roxithromycin Tablet 150 mg Oral Roxithromycin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[40]          Schedule 1, items dealing with Roxithromycin in the form Tablet
300 mg

omit from the columns in the order indicated:

Roxithromycin Tablet 300 mg Oral Roxithromycin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[41]          Schedule 1, items dealing with Simvastatin in the form Tablet 10 mg

(a) omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

(b)omit from the columns in the order indicated:

Simvastatin Tablet 10 mg Oral Simvastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[42]          Schedule 1, items dealing with Simvastatin in the form Tablet 20 mg

(a) omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

(b)omit from the columns in the order indicated:

Simvastatin Tablet 20 mg Oral Simvastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[43]          Schedule 1, items dealing with Simvastatin in the form Tablet 40 mg

(a) omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

(b)omit from the columns in the order indicated:

Simvastatin Tablet 40 mg Oral Simvastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[44]          Schedule 1, items dealing with Simvastatin in the form Tablet 5 mg

omit from the columns in the order indicated:

Simvastatin Tablet 5 mg Oral Simvastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481

[45]          Schedule 1, items dealing with Simvastatin in the form Tablet 80 mg

(a) omit from the column headed “Brand”:

Genepharm Australasia Limited

and substitute:

Genepharm Pty Ltd

(b)omit from the columns in the order indicated:

Simvastatin Tablet 80 mg Oral Simvastatin-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0